Susquehanna International Group, LLP Pfizer Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Pfizer Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 10,288,722 shares of PFE stock, worth $271 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,288,722

Previous 9,065,012 13.5%

Holding current value

$271 Million

Previous $254 Million 17.39%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $33.9 Million - $38.4 Million	1,223,710 Added 13.5%	10,288,722 $298 Million
Q2 2024 Aug 15, 2024	SELL	$25.26 - $29.6 $147 Million - $172 Million	-5,814,161 Reduced 39.08%	9,065,012 $254 Million
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $76.8 Million - $88.2 Million	-2,968,135 Reduced 16.63%	14,879,173 $413 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $286 Million - $372 Million	10,947,182 Added 158.65%	17,847,308 $514 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $79.3 Million - $92.6 Million	2,469,709 Added 55.74%	6,900,126 $229 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $152 Million - $176 Million	-4,217,985 Reduced 48.77%	4,430,417 $163 Million
Q1 2023 May 16, 2023	BUY	$39.39 - $51.28 $251 Million - $327 Million	6,382,870 Added 281.74%	8,648,402 $353 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $74.9 Million - $97.8 Million	1,794,154 Added 380.62%	2,265,532 $116 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $37.2 Million - $45.4 Million	-850,022 Reduced 64.33%	471,378 $20.6 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $5.07 Million - $6.02 Million	-109,046 Reduced 7.62%	1,321,400 $69.3 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $16.6 Million - $20.6 Million	-363,137 Reduced 20.25%	1,430,446 $74.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $182 Million - $271 Million	-4,416,414 Reduced 71.12%	1,793,583 $106 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $90.1 Million - $116 Million	-2,295,974 Reduced 26.99%	6,209,997 $267 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $41.1 Million - $46.5 Million	-1,143,813 Reduced 11.85%	8,505,971 $333 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $32.8 Million - $37 Million	-980,592 Reduced 9.22%	9,649,784 $350 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $30.6 Million - $38.9 Million	915,104 Added 9.42%	10,630,376 $391 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $16.4 Million - $19.3 Million	-517,873 Reduced 5.06%	9,715,272 $357 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $121 Million - $147 Million	4,017,232 Added 64.63%	10,233,145 $335 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $102 Million - $146 Million	3,779,372 Added 155.11%	6,215,913 $203 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $30.1 Million - $34.2 Million	914,793 Added 60.11%	2,436,541 $95.5 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $39.6 Million - $51.3 Million	1,218,105 Added 401.16%	1,521,748 $54.7 Million
Q2 2019 Aug 16, 2019	BUY	$36.98 - $41.52 $8 Million - $8.98 Million	216,265 Added 247.51%	303,643 $13.2 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $2.41 Million - $2.65 Million	64,284 Added 278.36%	87,378 $3.71 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $2.07 Million - $2.51 Million	-60,076 Reduced 72.23%	23,094 $1.02 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $152,103 - $162,157	4,612 Added 5.87%	83,170 $3.02 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $15.4 Million - $17.9 Million	-483,138 Reduced 86.01%	78,558 $2.79 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $17.4 Million - $19.2 Million	561,696	561,696 $20.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pfizer Inc Transaction History